GlobalData on MSN
Glooko acquires Monarch to advance diabetes platform reach
Glooko plans to develop an end-to-end ‘hospital-to-home’ care support provision for diabetes patients through the resources ...
Zacks.com on MSN
Growing Diagnostics Arm Supports ABT Stock, Macro Issues Ail
ABT gains momentum with strong FreeStyle Libre sales and Diagnostics growth but global macro headwinds weigh on performance.
Bizcommunity on MSN
Medshield launches 2026 product suite with 7.5% weighted average contribution increase
Medshield Medical Scheme launched its benefit options and contributions for 2026, building on its Partner for Life offering ...
In addition to strong earnings, Eli Lilly and Company (NYSE:LLY) has also been returning value to shareholders for years. The ...
PODD stock rallies 37.4% in a year, fueled by Omnipod 5 adoption, global launches and expanding reach in diabetes care.
Researchers at the Karolinska Institutet in Sweden have issued a warning over a red flag sign in your wee which could indicate a 25% higher risk of dementia ...
For the growing number of children with type 1 diabetes, the daily burden of managing their challenging chronic disease and ...
Diabetes insipidus is very different from diabetes mellitus. It has nothing to do with blood sugar. Instead, the problem is with a hormone called arginine vasopressin (AVP), also known as ...
Our platform, Mytonomy Cloud for Healthcare, blends consumer-style streaming with high-quality health content and digital ...
Dallara, president of Medtronic’s diabetes business, discussed the segment’s turnaround and why she sees a benefit in ...
Aqua Medical is targeting the duodenum with radiofrequency vapor ablation (RFVA) to treat patients with type 2 diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results